Non-Rule 10b5-1 Arrangement Modified [Flag] Non-Rule 10b5-1 Arrangement Adopted. Rule 10b5-1 Arrangement Modified [Flag] Rule 10b5-1 arrangement modified. Total current assets Total assets Total current liabilities Total liabilities Class of Stock [Axis] Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Product and Service [Axis] Gross profit Total operating expenses Loss from operations Net loss Net loss Net losses Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash used in investing activities Net cash provided by financing activities Net decrease in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash and cash equivalents The Company and Summary of Significant Accounting Policies [Abstract] Antidilutive Securities [Axis] Fair Value of Financial Instruments [Abstract] Measurement Frequency [Axis] Fair Value Hierarchy and NAV [Axis] Cash and Cash Equivalents [Axis] Balance Sheet Detail [Abstract] Schedule of Balance Sheet [Abstract] Inventories, net Inventories, net Accrued expenses and other Accrued expenses and other Commitments and Contingencies [Abstract] Schedule of Details of Right-of-Use Assets and Lease Liabilities [Abstract] Total right-of-use assets Right-of-use lease assets Total lease liabilities Schedule of Future Minimum Payments [Abstract] Total future lease payments Business Segments, Concentration of Credit Risk and Significant Customers [Abstract] Schedule of Segment Expenses and Other Segment Items [Abstract] Net revenue Segments [Axis] Geographical [Axis] Customer [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Type [Axis] Supplier [Axis] Stock-Based Compensation [Abstract] Statistical Measurement [Axis] Shares Available for Grant, Beginning Balance Shares Available for Grant, Ending Balance Number of Shares, Beginning Balance Number of Shares, Ending Balance Weighted Average Exercise Prices, Beginning Balance (in Dollars per share) Weighted Average Exercise Prices, Ending Balance (in Dollars per share) Exercise Price Range [Axis] Number of Shares, Non-Vested Beginning Balance Number of Shares, Non-vested Ending Balance Weighted Average Grant-Date Fair Value, Non-vested Beginning Balance Weighted Average Grant-Date Fair Value, Non-vested Ending Balance Stockholders’ Equity [Abstract] Warrants [Abstract] Class of Warrant or Right [Axis] Number of warrants on common shares, Beginning Balance Number of warrants on common shares, Ending Balance Warrants purchase for common stock Fair Value Amount, Beginning Balance Fair Value Amount, Ending Balance Warrant liabilities Measurement Input Type [Axis] Related Party Transactions [Abstract] Memory IC Product End-of-Life [Abstract] Subsequent Events [Abstract] ASSETS Current assets Accounts receivable, net Prepaid expenses and other Property and equipment, net Other LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable Deferred revenue Short-term lease liabilities Long-term lease liabilities Commitments and contingencies (Note 4) Stockholders’ equity Preferred stock, value Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized (in Shares) Preferred stock, shares issued (in Shares) Preferred stock, shares outstanding (in Shares) Common stock, $0.001 par value; 120,000 shares authorized; 12,582 shares and 10,055 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Common stock, par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares issued (in Shares) Common stock, shares outstanding (in Shares) Exchangeable shares, no par value; unlimited shares authorized; 56 shares outstanding at March 31, 2026 and December 31, 2025 Exchangeable shares, par value (in Dollars per share) Exchangeable shares, shares authorized Exchangeable shares, shares outstanding (in Shares) Issuable shares, none and 137 shares at March 31, 2026 and December 31, 2025, respectively Issuable shares (in Shares) Additional paid-in capital Accumulated deficit Total net revenue Product category Cost of net revenue Operating expenses Research and development Selling, general and administrative Other income (expense), net Net loss per share Basic (in Dollars per share) Diluted (in Dollars per share) Shares used in computing net loss per share Basic (in Shares) Diluted (in Shares) At-the market sales of stock, net At-the market sales of stock, net (in Shares) Issuance of common stock under stock plans Issuance of common stock under stock plans (in Shares) Issuance of abeyance shares Issuance of abeyance shares (in Shares) Stock-based compensation Shares issued for services Shares issued for services (in Shares) Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Stock-based compensation Change in fair value of warrant liabilities Change in fair value of warrant liabilities Fair Value Amount, Change in fair value of warrants Shares issued for services Inventory write downs Changes in assets and liabilities Accounts payable Right-of-use assets Lease liabilities - operating Deferred revenue, accrued expenses and other Cash flows from investing activities: Cash flows from financing activities: Proceeds from at-the-market sales of stock, net Proceeds from exercises of stock options Other Accounts receivable Inventories Prepaid expenses and other assets Purchases of property and equipment Repayment of financing lease Series A Special Voting Preferred Stock Product Product [Member] Services and other Common Stock Common Stock [Member] Issuable Shares Exchangeable Shares Additional Paid-In Capital Accumulated Deficit The Company and Summary of Significant Accounting Policies Schedule of Computation of Diluted Net Loss Per Share Total anti-dilutive securities Fair Value of Financial Instruments Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Assets: Money market funds Liabilities: Schedule of Determination of Fair Value for its Financial Assets (Cash Equivalents) Cost Unrealized Gains Fair Value Balance Sheet Detail Schedule of Balance Sheet Inventories: Raw materials Work-in-process Finished goods Prepaid expenses and other: Prepaid inventory and production costs Prepaid insurance Prepaid software Other Prepaid expenses and other Accrued Expenses & Other: Accrued wages and employee benefits Professional fees, legal and consulting Warranty accrual Other Commitments and Contingencies Schedule of Details of Right-of-Use Assets and Lease Liabilities Right-of-use assets: Operating leases Lease liabilities: Operating leases Present value of lease liabilities Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for leases Schedule of Future Minimum Payments 2026